Vanguard Group
ISEE

Vanguard Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Vanguard Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,678,616
Closed -$538M – 4631
2023
Q2 		$538M Buy
13,678,616
+17,227
+0.1% +$608K 0.01% 881
2023
Q1 		$332M Buy
13,661,389
+3,509,386
+35% +$76.8M 0.01% 1143
2022
Q4 		$217M Buy
10,152,003
+4,035,242
+66% +$86.1M 0.01% 1384
2022
Q3 		$110M Buy
6,116,761
+134,845
+2% +$1.77M ﹤0.01% 1735
2022
Q2 		$57.5M Buy
5,981,916
+203,187
+4% +$2.55M ﹤0.01% 2132
2022
Q1 		$97.3M Buy
5,778,729
+99,606
+2% +$1.47M ﹤0.01% 1957
2021
Q4 		$95M Buy
5,679,123
+817,537
+17% +$13.4M ﹤0.01% 2011
2021
Q3 		$79M Buy
4,861,586
+663,864
+16% +$7.22M ﹤0.01% 2111
2021
Q2 		$26.5M Sell
4,197,722
-27,565
-0.7% -$178K ﹤0.01% 2700
2021
Q1 		$26.1M Buy
4,225,287
+61,671
+1% +$374K ﹤0.01% 2643
2020
Q4 		$28.8M Buy
4,163,616
+223,202
+6% +$1.43M ﹤0.01% 2467
2020
Q3 		$22.2M Buy
3,940,414
+1,661,769
+73% +$7.92M ﹤0.01% 2402
2020
Q2 		$11.6M Buy
2,278,645
+212,190
+10% +$884K ﹤0.01% 2694
2020
Q1 		$7.11M Buy
2,066,455
+284,971
+16% +$1.67M ﹤0.01% 2784
2019
Q4 		$15.3M Buy
1,781,484
+615,507
+53% +$2.2M ﹤0.01% 2656
2019
Q3 		$1.31M Buy
1,165,977
+30,608
+3% +$35.6K ﹤0.01% 3571
2019
Q2 		$1.48M Buy
1,135,369
+207,554
+22% +$285K ﹤0.01% 3561
2019
Q1 		$1.31M Buy
927,815
+286,411
+45% +$401K ﹤0.01% 3557
2018
Q4 		$769K Sell
641,404
-1,161,429
-64% -$2.25M ﹤0.01% 3638
2018
Q3 		$4.25M Buy
1,802,833
+83,837
+5% +$209K ﹤0.01% 3294
2018
Q2 		$4.69M Buy
1,718,996
+73,734
+4% +$203K ﹤0.01% 3232
2018
Q1 		$4.51M Buy
1,645,262
+282,736
+21% +$820K ﹤0.01% 3190
2017
Q4 		$4.25M Sell
1,362,526
-903,062
-40% -$2.54M ﹤0.01% 3194
2017
Q3 		$6.39M Sell
2,265,588
-19,462
-0.9% -$52.6K ﹤0.01% 3015
2017
Q2 		$5.85M Sell
2,285,050
-528,670
-19% -$1.44M ﹤0.01% 3033
2017
Q1 		$10.3M Buy
2,813,720
+14,766
+0.5% +$62.4K ﹤0.01% 2757
2016
Q4 		$13.5M Buy
2,798,954
+442,623
+19% +$13.1M ﹤0.01% 2602
2016
Q3 		$109M Buy
2,356,331
+144,786
+7% +$8.16M 0.01% 1505
2016
Q2 		$113M Buy
2,211,545
+231,933
+12% +$11.5M 0.01% 1438
2016
Q1 		$83.7M Buy
1,979,612
+157,582
+9% +$8.03M 0.01% 1592
2015
Q4 		$143M Buy
1,822,030
+50,837
+3% +$2.94M 0.01% 1216
2015
Q3 		$71.8M Buy
1,771,193
+366,835
+26% +$19.4M 0.01% 1661
2015
Q2 		$73.1M Buy
1,404,358
+98,633
+8% +$4.91M ﹤0.01% 1735
2015
Q1 		$60.8M Buy
1,305,725
+81,017
+7% +$4.21M ﹤0.01% 1816
2014
Q4 		$55M Buy
1,224,708
+268,052
+28% +$11.3M ﹤0.01% 1787
2014
Q3 		$37.2M Buy
956,656
+77,265
+9% +$3.03M ﹤0.01% 1950
2014
Q2 		$37.2M Buy
879,391
+339,977
+63% +$12.5M ﹤0.01% 1975
2014
Q1 		$19.3M Buy
539,414
+357,115
+196% +$12M ﹤0.01% 2198
2013
Q4 		$5.9M Buy
+182,299
New +$5.41M ﹤0.01% 2706

Vanguard Group's ISEE Position: Q3 2023 in Review

Vanguard Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 13,678,616 shares — an estimated $538M sold.

Vanguard Group first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $538M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Vanguard Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 13,678,616 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $538M.
  • Vanguard Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Vanguard Group's IVERIC bio, Inc. Common Stock position peaked at $538M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.